Amrinona
Amrinona Uses, Dosage, Side Effects, Food Interaction and all others data.
Amrinona (or inamrinone) is a type 3 pyridine phosphodiesterase inhibitor. It is used in the treatment of congestive heart failure.
Amrinona is a positive inotropic cardiotonic with vasodilator properties, phosphodiesterase inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
Trade Name | Amrinona |
Generic | Amrinone |
Amrinone Other Names | Amrinona, Amrinone, Amrinonum, Inamrinone |
Type | |
Formula | C10H9N3O |
Weight | Average: 187.198 Monoisotopic: 187.074561925 |
Protein binding | 10 to 49% |
Groups | Approved |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Amrinona is a positive inotropic agent and phosphodiesterase inhibitor used in the management of treatment of congestive heart failure.
Used in the treatment of congestive heart failure.
How Amrinona works
Amrinona is a phosphodiesterase inhibitor (PDE3), resulting in increased cAMP and cGMP which leads to an increase in the calcium influx like that caused by beta-agonists resulting in increased inotropic effect.
Volume of Distribution
- 1.2 L/kg [normal volunteers]
Half Life
5 to 8 hours
Elimination Route
The primary route of excretion in man is via the urine as both inamrinone and several metabolites (N-glycolyl, N-acetate, O-glucuronide and N-glucuronide).
Innovators Monograph
You find simplified version here Amrinona